Long-term impact of contact precautions cessation for Methicillin-Resistant Staphylococcus Aureus (MRSA)

•Contact Isolation is a recommended infection prevention measure against Methicillin-Resistant Staphylococcus aureus (MRSA) healthcare-associated infections (HAI).•Growing evidence suggest MRSA contact isolation may not be effective.•Discontinuation of MRSA contact isolation did not affect MRSA HAI...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of infection control 2022-03, Vol.50 (3), p.336-341
Hauptverfasser: AlMohanna, Zainab, Snavely, Anna C., Viviano, James P, Bischoff, Werner E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 341
container_issue 3
container_start_page 336
container_title American journal of infection control
container_volume 50
creator AlMohanna, Zainab
Snavely, Anna C.
Viviano, James P
Bischoff, Werner E.
description •Contact Isolation is a recommended infection prevention measure against Methicillin-Resistant Staphylococcus aureus (MRSA) healthcare-associated infections (HAI).•Growing evidence suggest MRSA contact isolation may not be effective.•Discontinuation of MRSA contact isolation did not affect MRSA HAI over time.•MRSA isolation discontinuation improves individual patient care and saves costs. Methicillin-Resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-associated infections (HAI). Contact isolation has been traditionally implemented to stop transmission but its impact is increasingly questioned. A single center, retrospective, nonrandomized, observational, quasi-experimental study compared MRSA HAI rates between pre-/postdiscontinuation of MRSA contact isolation in a tertiary university hospital over 68 months. Data on primary outcomes, Central line-associated bloodstream infections and MRSA LabID bacteremia events, were analyzed by interrupted time series design using segmented Poisson regression modeling. As secondary outcomes catheter-associated urinary tract infections , ventilator-associated pneumonia , surgical site infections and hospital-associated pneumonia were compared using Fisher's exact tests. Current savings due to discontinuation were calculated based on gown use. Two hundred and ninty-five patients developed 399 HAIs. Infection rates between pre- and postinterventions were as follows: Central line-associated bloodstream infections: (0.02% vs 0.02%; P-value = .64), MRSA LabID events: (0.01% vs 0.02%; P-value = .32), hospital-associated pneumonia: (0.01% vs 0.01%; P-value = .64), catheter-associated urinary tract infections: (0% vs 0.01%; P-value = .56), ventilator-associated pneumonia: (0.01% vs 0.01%; P-value = .32), surgical site infections (0.55% vs 0.15%; P-value = .03). Savings amount to $139,228 annually. Discontinuing CP did not negatively impact endemic MRSA HAI rates between pre-postdiscontinuation periods and saved costs for isolation materials.
doi_str_mv 10.1016/j.ajic.2021.10.044
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2599184444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0196655321007483</els_id><sourcerecordid>2599184444</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-ac3508a2f0759408e4b7bac18cd71c8a80962f73997b5a2099899d86bfcbf7a03</originalsourceid><addsrcrecordid>eNp9kM1r3DAQxUVJaTZJ_4Eeio_pwduR_CVBLktoPmBDIWnOQh6Pu1psy5XkQP772Nk0x8xlHsN7D-bH2DcOaw68_Llfm73FtQDB58Ma8vwTW_FCVGkmVHnEVsBVmZZFkR2zkxD2AKCysvjCjrO8UplUfMV2Wzf8TSP5PrH9aDAmrk3QDXGRoyc0U7RuCAlSCGaRSet8ckdxZ9F2nR3Sewo2RDPE5CGacffcOXSIU0g2k6d5nd_dP2x-nLHPrekCfX3bp-zx6tefy5t0-_v69nKzTTEHiKnBrABpRAtVoXKQlNdVbZBLbCqO0khQpWirTKmqLowApaRSjSzrFuu2MpCdsvND7-jdv4lC1L0NSF1nBnJT0KJQist8ntkqDlb0LgRPrR697Y1_1hz0Qljv9UJYL4SXG7yGvr_1T3VPzXvkP9LZcHEw0PzlkyWvA1oakBo744y6cfaj_hd10Y1l</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2599184444</pqid></control><display><type>article</type><title>Long-term impact of contact precautions cessation for Methicillin-Resistant Staphylococcus Aureus (MRSA)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>AlMohanna, Zainab ; Snavely, Anna C. ; Viviano, James P ; Bischoff, Werner E.</creator><creatorcontrib>AlMohanna, Zainab ; Snavely, Anna C. ; Viviano, James P ; Bischoff, Werner E.</creatorcontrib><description>•Contact Isolation is a recommended infection prevention measure against Methicillin-Resistant Staphylococcus aureus (MRSA) healthcare-associated infections (HAI).•Growing evidence suggest MRSA contact isolation may not be effective.•Discontinuation of MRSA contact isolation did not affect MRSA HAI over time.•MRSA isolation discontinuation improves individual patient care and saves costs. Methicillin-Resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-associated infections (HAI). Contact isolation has been traditionally implemented to stop transmission but its impact is increasingly questioned. A single center, retrospective, nonrandomized, observational, quasi-experimental study compared MRSA HAI rates between pre-/postdiscontinuation of MRSA contact isolation in a tertiary university hospital over 68 months. Data on primary outcomes, Central line-associated bloodstream infections and MRSA LabID bacteremia events, were analyzed by interrupted time series design using segmented Poisson regression modeling. As secondary outcomes catheter-associated urinary tract infections , ventilator-associated pneumonia , surgical site infections and hospital-associated pneumonia were compared using Fisher's exact tests. Current savings due to discontinuation were calculated based on gown use. Two hundred and ninty-five patients developed 399 HAIs. Infection rates between pre- and postinterventions were as follows: Central line-associated bloodstream infections: (0.02% vs 0.02%; P-value = .64), MRSA LabID events: (0.01% vs 0.02%; P-value = .32), hospital-associated pneumonia: (0.01% vs 0.01%; P-value = .64), catheter-associated urinary tract infections: (0% vs 0.01%; P-value = .56), ventilator-associated pneumonia: (0.01% vs 0.01%; P-value = .32), surgical site infections (0.55% vs 0.15%; P-value = .03). Savings amount to $139,228 annually. Discontinuing CP did not negatively impact endemic MRSA HAI rates between pre-postdiscontinuation periods and saved costs for isolation materials.</description><identifier>ISSN: 0196-6553</identifier><identifier>EISSN: 1527-3296</identifier><identifier>DOI: 10.1016/j.ajic.2021.10.044</identifier><identifier>PMID: 34793891</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Bacteremia - epidemiology ; Bacteremia - prevention &amp; control ; Central Line Associated Bloodstream Infections ; Contact precautions ; Cross Infection - epidemiology ; Cross Infection - prevention &amp; control ; Healthcare associated infections ; Humans ; Infection Control ; Methicillin-Resistant Staphylococcus aureus ; MRSA bacteremia LabID events ; Personal protective equipment ; Retrospective Studies ; Staphylococcal Infections - epidemiology ; Staphylococcal Infections - prevention &amp; control</subject><ispartof>American journal of infection control, 2022-03, Vol.50 (3), p.336-341</ispartof><rights>2021 The Authors</rights><rights>Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-ac3508a2f0759408e4b7bac18cd71c8a80962f73997b5a2099899d86bfcbf7a03</citedby><cites>FETCH-LOGICAL-c400t-ac3508a2f0759408e4b7bac18cd71c8a80962f73997b5a2099899d86bfcbf7a03</cites><orcidid>0000-0003-1388-3642 ; 0000-0002-3083-3279 ; 0000-0001-6916-4255 ; 0000-0002-2468-4406</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ajic.2021.10.044$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34793891$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AlMohanna, Zainab</creatorcontrib><creatorcontrib>Snavely, Anna C.</creatorcontrib><creatorcontrib>Viviano, James P</creatorcontrib><creatorcontrib>Bischoff, Werner E.</creatorcontrib><title>Long-term impact of contact precautions cessation for Methicillin-Resistant Staphylococcus Aureus (MRSA)</title><title>American journal of infection control</title><addtitle>Am J Infect Control</addtitle><description>•Contact Isolation is a recommended infection prevention measure against Methicillin-Resistant Staphylococcus aureus (MRSA) healthcare-associated infections (HAI).•Growing evidence suggest MRSA contact isolation may not be effective.•Discontinuation of MRSA contact isolation did not affect MRSA HAI over time.•MRSA isolation discontinuation improves individual patient care and saves costs. Methicillin-Resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-associated infections (HAI). Contact isolation has been traditionally implemented to stop transmission but its impact is increasingly questioned. A single center, retrospective, nonrandomized, observational, quasi-experimental study compared MRSA HAI rates between pre-/postdiscontinuation of MRSA contact isolation in a tertiary university hospital over 68 months. Data on primary outcomes, Central line-associated bloodstream infections and MRSA LabID bacteremia events, were analyzed by interrupted time series design using segmented Poisson regression modeling. As secondary outcomes catheter-associated urinary tract infections , ventilator-associated pneumonia , surgical site infections and hospital-associated pneumonia were compared using Fisher's exact tests. Current savings due to discontinuation were calculated based on gown use. Two hundred and ninty-five patients developed 399 HAIs. Infection rates between pre- and postinterventions were as follows: Central line-associated bloodstream infections: (0.02% vs 0.02%; P-value = .64), MRSA LabID events: (0.01% vs 0.02%; P-value = .32), hospital-associated pneumonia: (0.01% vs 0.01%; P-value = .64), catheter-associated urinary tract infections: (0% vs 0.01%; P-value = .56), ventilator-associated pneumonia: (0.01% vs 0.01%; P-value = .32), surgical site infections (0.55% vs 0.15%; P-value = .03). Savings amount to $139,228 annually. Discontinuing CP did not negatively impact endemic MRSA HAI rates between pre-postdiscontinuation periods and saved costs for isolation materials.</description><subject>Bacteremia - epidemiology</subject><subject>Bacteremia - prevention &amp; control</subject><subject>Central Line Associated Bloodstream Infections</subject><subject>Contact precautions</subject><subject>Cross Infection - epidemiology</subject><subject>Cross Infection - prevention &amp; control</subject><subject>Healthcare associated infections</subject><subject>Humans</subject><subject>Infection Control</subject><subject>Methicillin-Resistant Staphylococcus aureus</subject><subject>MRSA bacteremia LabID events</subject><subject>Personal protective equipment</subject><subject>Retrospective Studies</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcal Infections - prevention &amp; control</subject><issn>0196-6553</issn><issn>1527-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1r3DAQxUVJaTZJ_4Eeio_pwduR_CVBLktoPmBDIWnOQh6Pu1psy5XkQP772Nk0x8xlHsN7D-bH2DcOaw68_Llfm73FtQDB58Ma8vwTW_FCVGkmVHnEVsBVmZZFkR2zkxD2AKCysvjCjrO8UplUfMV2Wzf8TSP5PrH9aDAmrk3QDXGRoyc0U7RuCAlSCGaRSet8ckdxZ9F2nR3Sewo2RDPE5CGacffcOXSIU0g2k6d5nd_dP2x-nLHPrekCfX3bp-zx6tefy5t0-_v69nKzTTEHiKnBrABpRAtVoXKQlNdVbZBLbCqO0khQpWirTKmqLowApaRSjSzrFuu2MpCdsvND7-jdv4lC1L0NSF1nBnJT0KJQist8ntkqDlb0LgRPrR697Y1_1hz0Qljv9UJYL4SXG7yGvr_1T3VPzXvkP9LZcHEw0PzlkyWvA1oakBo744y6cfaj_hd10Y1l</recordid><startdate>202203</startdate><enddate>202203</enddate><creator>AlMohanna, Zainab</creator><creator>Snavely, Anna C.</creator><creator>Viviano, James P</creator><creator>Bischoff, Werner E.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1388-3642</orcidid><orcidid>https://orcid.org/0000-0002-3083-3279</orcidid><orcidid>https://orcid.org/0000-0001-6916-4255</orcidid><orcidid>https://orcid.org/0000-0002-2468-4406</orcidid></search><sort><creationdate>202203</creationdate><title>Long-term impact of contact precautions cessation for Methicillin-Resistant Staphylococcus Aureus (MRSA)</title><author>AlMohanna, Zainab ; Snavely, Anna C. ; Viviano, James P ; Bischoff, Werner E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-ac3508a2f0759408e4b7bac18cd71c8a80962f73997b5a2099899d86bfcbf7a03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Bacteremia - epidemiology</topic><topic>Bacteremia - prevention &amp; control</topic><topic>Central Line Associated Bloodstream Infections</topic><topic>Contact precautions</topic><topic>Cross Infection - epidemiology</topic><topic>Cross Infection - prevention &amp; control</topic><topic>Healthcare associated infections</topic><topic>Humans</topic><topic>Infection Control</topic><topic>Methicillin-Resistant Staphylococcus aureus</topic><topic>MRSA bacteremia LabID events</topic><topic>Personal protective equipment</topic><topic>Retrospective Studies</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcal Infections - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AlMohanna, Zainab</creatorcontrib><creatorcontrib>Snavely, Anna C.</creatorcontrib><creatorcontrib>Viviano, James P</creatorcontrib><creatorcontrib>Bischoff, Werner E.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of infection control</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AlMohanna, Zainab</au><au>Snavely, Anna C.</au><au>Viviano, James P</au><au>Bischoff, Werner E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-term impact of contact precautions cessation for Methicillin-Resistant Staphylococcus Aureus (MRSA)</atitle><jtitle>American journal of infection control</jtitle><addtitle>Am J Infect Control</addtitle><date>2022-03</date><risdate>2022</risdate><volume>50</volume><issue>3</issue><spage>336</spage><epage>341</epage><pages>336-341</pages><issn>0196-6553</issn><eissn>1527-3296</eissn><abstract>•Contact Isolation is a recommended infection prevention measure against Methicillin-Resistant Staphylococcus aureus (MRSA) healthcare-associated infections (HAI).•Growing evidence suggest MRSA contact isolation may not be effective.•Discontinuation of MRSA contact isolation did not affect MRSA HAI over time.•MRSA isolation discontinuation improves individual patient care and saves costs. Methicillin-Resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-associated infections (HAI). Contact isolation has been traditionally implemented to stop transmission but its impact is increasingly questioned. A single center, retrospective, nonrandomized, observational, quasi-experimental study compared MRSA HAI rates between pre-/postdiscontinuation of MRSA contact isolation in a tertiary university hospital over 68 months. Data on primary outcomes, Central line-associated bloodstream infections and MRSA LabID bacteremia events, were analyzed by interrupted time series design using segmented Poisson regression modeling. As secondary outcomes catheter-associated urinary tract infections , ventilator-associated pneumonia , surgical site infections and hospital-associated pneumonia were compared using Fisher's exact tests. Current savings due to discontinuation were calculated based on gown use. Two hundred and ninty-five patients developed 399 HAIs. Infection rates between pre- and postinterventions were as follows: Central line-associated bloodstream infections: (0.02% vs 0.02%; P-value = .64), MRSA LabID events: (0.01% vs 0.02%; P-value = .32), hospital-associated pneumonia: (0.01% vs 0.01%; P-value = .64), catheter-associated urinary tract infections: (0% vs 0.01%; P-value = .56), ventilator-associated pneumonia: (0.01% vs 0.01%; P-value = .32), surgical site infections (0.55% vs 0.15%; P-value = .03). Savings amount to $139,228 annually. Discontinuing CP did not negatively impact endemic MRSA HAI rates between pre-postdiscontinuation periods and saved costs for isolation materials.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>34793891</pmid><doi>10.1016/j.ajic.2021.10.044</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-1388-3642</orcidid><orcidid>https://orcid.org/0000-0002-3083-3279</orcidid><orcidid>https://orcid.org/0000-0001-6916-4255</orcidid><orcidid>https://orcid.org/0000-0002-2468-4406</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0196-6553
ispartof American journal of infection control, 2022-03, Vol.50 (3), p.336-341
issn 0196-6553
1527-3296
language eng
recordid cdi_proquest_miscellaneous_2599184444
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Bacteremia - epidemiology
Bacteremia - prevention & control
Central Line Associated Bloodstream Infections
Contact precautions
Cross Infection - epidemiology
Cross Infection - prevention & control
Healthcare associated infections
Humans
Infection Control
Methicillin-Resistant Staphylococcus aureus
MRSA bacteremia LabID events
Personal protective equipment
Retrospective Studies
Staphylococcal Infections - epidemiology
Staphylococcal Infections - prevention & control
title Long-term impact of contact precautions cessation for Methicillin-Resistant Staphylococcus Aureus (MRSA)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T21%3A43%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-term%20impact%20of%20contact%20precautions%20cessation%20for%20Methicillin-Resistant%20Staphylococcus%20Aureus%20(MRSA)&rft.jtitle=American%20journal%20of%20infection%20control&rft.au=AlMohanna,%20Zainab&rft.date=2022-03&rft.volume=50&rft.issue=3&rft.spage=336&rft.epage=341&rft.pages=336-341&rft.issn=0196-6553&rft.eissn=1527-3296&rft_id=info:doi/10.1016/j.ajic.2021.10.044&rft_dat=%3Cproquest_cross%3E2599184444%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2599184444&rft_id=info:pmid/34793891&rft_els_id=S0196655321007483&rfr_iscdi=true